clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03057314 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
P17 | country | Israel | Q801 |
P582 | end time | 2019-05-31 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 20 | |
P4844 | research intervention | calcium oxalate | Q412399 |
calcium carbonate | Q23767 | ||
P580 | start time | 2017-06-25 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Exploratory, Open Label Study to Improve Function and Welfare of Late-stage Cancer Subjects by Amorphous Calcium Carbonate (ACC) Treatment, Administered Orally and Concomitantly With Inhalation |